Gearing up for third vaccine doses for the immunocompromisedEligible patients will require a letter from their physician to receive a third dose, but pharmacists can assist in identifying candidates Quiz: How much do you know about PrEP and HIV?How much do you know about pre-exposure prophylaxis (PrEP) to prevent HIV in people at high risk for the infection? Cross-country snapshot of unvaccinated Canadian healthcare workers Many are not immune to COVID-19 conspiracy theories and misinformation. Pfizer COVID-19 vaccine unlikely to cause relapse of Guillain-Barré syndrome Study suggests minimal risk of relapse when Pfizer-BioNTech mRNA COVID-19 vaccine is given to patients with a history of GBS. Ivermectin: efficacy and safety data lacking for COVID-19 prevention or treatment Health Canada advises consumers not use veterinary or human dosage forms of ivermectin to prevent or treat COVID-19. Vaccine hesitancy highest in Alberta, racialized groups at rollout's start: survey The survey, led by researchers at Toronto's St. Michael's Hospital, was published online Tuesday in The Lancet Regional Health–Americas. Six things to tell patients about the Delta variant of SARS-CoV-2 Spreads faster than early forms of SARS-CoV-2 and is now the predominant variant in Canada and the United States One jab has almost no effect against Delta: study According to a recently published study, two shots are better than one when it comes to protection against the SARS-CoV-2 Delta, as well as other, variants of the virus. J&J: Potential HIV vaccine falls short in mid stage study The study in sub-Saharan Africa involved about 2,600 women who were deemed to be at high risk of acquiring HIV, which causes AIDS. Ontario's Vaccine Clinical Advisory Group recommends some cohorts receive third mRNA vaccine The update outlines the specific populations who would most benefit from a third or booster shot. First Previous 62 63 64 65 66 Next Last
